The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial.

[1]  Kyung-Ja Cho,et al.  FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer. , 2005, International journal of radiation oncology, biology, physics.

[2]  J. Ajani,et al.  Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma , 2005, Cancer.

[3]  R. Cerfolio,et al.  The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. , 2005, The Journal of thoracic and cardiovascular surgery.

[4]  R. Munden,et al.  Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. , 2004, The Annals of thoracic surgery.

[5]  H. Groen,et al.  Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  S. Larson,et al.  Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Keigo Endo,et al.  Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer. , 2002, American journal of surgery.

[8]  M. Schwaiger,et al.  Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma: Response Evaluation by Positron Emission Tomography , 2001, Annals of surgery.

[9]  G. Urso,et al.  Role of positron emission tomography in staging esophageal cancer. , 1997, The Annals of thoracic surgery.

[10]  G. Patterson,et al.  Improvement in staging of esophageal cancer with the addition of positron emission tomography. , 1997, The Annals of thoracic surgery.

[11]  F Dehdashti,et al.  Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. , 1997, AJR. American journal of roentgenology.

[12]  S. Green,et al.  Planned versus attained design in phase II clinical trials. , 1992, Statistics in medicine.